Trends in the treatment of localized prostate cancer using supplemented cancer registry data.
about
Current clinical challenges in prostate cancerManagement of low (favourable)-risk prostate cancerUnderascertainment of radiotherapy receipt in Surveillance, Epidemiology, and End Results registry data.Increasing use of observation among men at low risk for prostate cancer mortality.Physician variation in management of low-risk prostate cancer: a population-based cohort studyClinical and Demographic Factors Associated With Receipt of Non Guideline-concordant Initial Therapy for Nonmetastatic Prostate Cancer.Historical prostate cancer screening and treatment outcomes from a single institutionGleason score 6 adenocarcinoma: should it be labeled as cancer?The change of prostate cancer treatment in Korea: 5 year analysis of a single institution.Regional, provider, and economic factors associated with the choice of active surveillance in the treatment of men with localized prostate cancer.Optimizing the management of prostate cancer in senior adults: call to actionA comment on the International Society of Geriatric Oncology guidelines: evidence-based advice for the clinical setting.Impact of race on survival in patients with clinically nonmetastatic prostate cancer who deferred primary treatment.Patients' Survival Expectations With and Without Their Chosen Treatment for Prostate Cancer.Differentiation of lethal and non lethal prostate cancer: PSA and PSA isoforms and kinetics.Treatment and Mortality in Men with Localized Prostate Cancer: A Population-Based Study in California.Use of prostate-specific antigen testing as a disease surveillance tool following radical prostatectomy.Racial and socioeconomic disparities in the selection of prostate brachytherapyUtilization of prostate brachytherapy for low risk prostate cancer: Is the decline overstated?Role of HMG-CoA reductase inhibitors with curative radiotherapy in men with prostate cancer.Type and dose of radiotherapy used for initial treatment of non-metastatic prostate cancerManagement of advanced prostate cancer in senior adults: the new landscape.Trends in the use of radiation therapy for stage IIA prostate cancer from 2004 to 2013: a retrospective analysis using the National Cancer Database.Racial Differences in Treatment Decision-Making for Men with Clinically Localized Prostate Cancer: a Population-Based Study.Trends in prostate cancer in elderly in Denmark, 1980-2012.Survival disparities between Māori and non-Māori men with prostate cancer in New Zealand.Is radical prostatectomy a useful therapeutic option for high-risk prostate cancer in older men?Radical radiotherapy for high-risk prostate cancer in older menSalvage open radical prostatectomy after failed radiation therapy: a single center experience.It is time to start active treatment in senior adults with prostate cancer.Determinants of the combined use of external beam radiotherapy and brachytherapy for low-risk, clinically localized prostate cancer.Tobacco use and external beam radiation therapy for prostate cancer: Influence on biochemical control and late toxicity.Multidisciplinary care in patients with prostate cancer: room for improvement.Management of metastatic prostate cancer in the elderly: identifying fitness for chemotherapy in the post-STAMPEDE world.More Judicious Use of Expectant Management for Localized Prostate Cancer during the Last 2 Decades.
P2860
Q26866036-3AA35F27-D8C9-4E0C-9603-2E1A2BD61E71Q26996501-334AC0ED-269E-400C-84FE-6B567BA5DABCQ33946846-99E43315-9ADF-4BE2-9705-86B74E43F23AQ35186071-BC374BB9-6E30-4F30-AD0D-D9428B151333Q35213290-C3D8FB61-5912-4C3C-B973-2F28E4D3C0EBQ35888084-10BBA465-CE60-4F59-BF1C-E6B751A2FE01Q36170995-50518115-6E26-4A8B-BF78-1765744EBFBAQ36449197-77070F8B-06E5-4A57-AE15-EC572DCD89BCQ36463890-32A08873-3B91-49BE-9292-954A41D6A2DFQ36520534-212BE70C-0253-4808-A012-DC34FA426291Q36672782-D0E87062-8B3F-4E3D-96FE-550923394086Q36672793-DC1D582A-5C71-4F2A-BD18-3DECD8C40291Q36757436-4E270F17-8663-4F61-9C76-88786E550109Q36905270-592245AD-BDA3-4E76-BEC8-F3802DA8CFF0Q37037804-E2FBD588-3F7A-4B41-9A1D-FFBEA7B1B7C5Q37134562-33073CD9-4956-4053-B8B9-5FA4E0DE7A84Q37209802-41D88DF8-5309-41E4-8020-1CC8FDE4EB79Q37231596-9D9DDFA2-D1FF-4AE8-B2A7-951D8094CFC0Q37246911-7D4C289C-48C1-4418-AA43-74ECDA452182Q37283766-6D14604C-57C9-406A-AF2C-84AC51EE2976Q37613018-D702361C-E59F-4F4E-B97D-8744A08092DDQ38046826-24358535-C07C-40E0-A391-4DDDFB57E920Q38842698-C54B40F8-31F3-406C-B5A5-D946F8AEA577Q39983159-1D00FC09-84C3-4DFF-8402-DA6ECF7948F4Q40090240-C0BC1308-8505-4BCD-BF89-70532B5E419AQ40214909-51BD3989-37A7-4B12-A4D8-56FDC37FCDFBQ41334393-F82AC048-5331-4211-976B-9C52D712F3BDQ41334584-8D7BD6AB-95D6-41A5-9925-633157AAF2E5Q41948711-52EFED95-5300-458C-9DE2-B675D38A5FF6Q44102241-6C4E030C-D379-4A82-9562-5F08824595EDQ44600654-D890A717-C11B-4447-98BF-6D2BD89BAF19Q44678220-D1AADCD6-4E3C-4006-96E8-16005C0FFB1EQ45728481-FC423F6A-0E04-4E18-A564-BBB92A561D75Q48189286-A5C865B5-4C2C-442F-980A-883D7BCD8E22Q50326934-FEAC16C1-3939-47AD-B8DE-2F27BFA77358
P2860
Trends in the treatment of localized prostate cancer using supplemented cancer registry data.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Trends in the treatment of loc ...... lemented cancer registry data.
@ast
Trends in the treatment of loc ...... lemented cancer registry data.
@en
type
label
Trends in the treatment of loc ...... lemented cancer registry data.
@ast
Trends in the treatment of loc ...... lemented cancer registry data.
@en
prefLabel
Trends in the treatment of loc ...... lemented cancer registry data.
@ast
Trends in the treatment of loc ...... lemented cancer registry data.
@en
P2093
P2860
P50
P1433
P1476
Trends in the treatment of loc ...... lemented cancer registry data.
@en
P2093
Ann S Hamilton
Donna Morrell
Peter C Albertsen
Terri Kang Johnson
P2860
P304
P356
10.1111/J.1464-410X.2010.09514.X
P577
2010-08-24T00:00:00Z